StackLeaf
Stock · NSE

LUPIN

2,201.80▲ 0.30 (0.01%)
Last 2 days · 15m candles25/8/2026, 00:35:15
Open: 2,218.20High: 2,218.20Low: 2,188.10Prev: 2,201.50
Positive
9
Neutral
8
Negative
2

News mentioning LUPIN

Sentiment: +37%← All news
VERIFIEDET Finance·4d★ ON YOUR LIST
Lupin arm to commercialise YUVEZZI eye drop across key European markets
AI summary· NEUTRAL
  • ·Lupin's VISUfarma BV has obtained exclusive rights for the YUVEZZI eye drop in major European markets.
  • ·YUVEZZI is an ophthalmic product designed to treat loss of clear close-up vision in adults.
  • ·VISUfarma will manage regulatory processes and the commercial launch of the eye drop.
LUPIN
VERIFIEDET Stocks·17d★ ON YOUR LIST
Lupin Q1 PAT rises 16 pc at Rs 1,417 cr
AI summary· POSITIVE
  • ·Lupin Ltd reported a 16% surge in profit after tax for the first quarter.
  • ·Consolidated total revenue from operations saw considerable growth.
  • ·Sales in the US market increased by 42%, and India sales rose by nearly 14%.
LUPIN
VERIFIEDET Finance·24d★ ON YOUR LIST
Lupin launches generic Sugammadex injection in US
AI summary· NEUTRAL
  • ·Lupin Limited has launched its Sugammadex Injection in the United States.
  • ·The launch follows approval from the US Food and Drug Administration.
  • ·The injection is indicated for reversing neuromuscular blockade in surgical patients.
LUPIN
VERIFIEDMint Markets·33d★ ON YOUR LIST
Top Gainers & Losers on 22 July: Bandhan Bank, PG Electroplast, Lupin, Delhivery, Voltas, IndiGo among top losers
AI summary· NEGATIVE
  • ·The Indian stock market experienced a sell-off on July 22, with the Nifty 50 closing 0.77% lower.
  • ·Middle East tensions and concerns over US tariffs on pharmaceuticals contributed to the market decline.
  • ·Broader markets fell over 1%, with Nifty Media and Nifty Pharma sectors seeing significant drops.
BANDHANBNKLUPINDELHIVERYVOLTASNIFTYNIFTYPHARMAINDIGO
VERIFIEDMint Markets·33d★ ON YOUR LIST
Lupin, Sun Pharma to Cipla: Pharma stocks decline after Trump’s tariffs plan on generic medicines import
AI summary· NEGATIVE
  • ·Several Indian pharmaceutical companies experienced a decline in their stock prices.
  • ·Aurobindo Pharma, Ajanta Pharma, Lupin, Gland Pharma, and Zydus Lifesciences were among the top decliners.
  • ·The decline occurred following a plan by Donald Trump regarding tariffs on generic medicine imports.
SUNPHARMACIPLALUPINAUROPHARMANIFTYNIFTYPHARMAGLANDZYDUSLIFE
VERIFIEDET Finance·59d★ ON YOUR LIST
Lupin gets USFDA tentative approval for prostate cancer treatment drug
AI summary· POSITIVE
  • ·Lupin Ltd has received tentative approval from the US FDA for its generic enzalutamide tablets.
  • ·The drug is used for the treatment of advanced prostate cancer.
  • ·The approval covers multiple strengths: 40 mg, 80 mg, 120 mg, and 160 mg.
LUPIN
VERIFIEDMint Markets·72d★ ON YOUR LIST
Stocks to buy: 3 stocks to beat the market in 2026: YES Securities lists Entero, Maruti and Lupin as June stock picks
AI summary· POSITIVE
  • ·YES Securities has identified Entero Healthcare, Maruti Suzuki, and Lupin as their top stock picks for June 2026.
  • ·These selections are based on strong sector dynamics, improving financial performance, and positive growth outlooks.
  • ·Potential price increases of 20% to 21% are anticipated for these stocks.
MARUTILUPIN